Monoclonal Antibody Therapeutics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Monoclonal Antibody Therapeutics Market to 2027 - Global Analysis and Forecasts By Type (Human, Humanized, Chimeric and Others); Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases and Others); End User (Hospitals, Private Clinics and Research Institute) and Geography

Report Code: TIPRE00003417 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to bind specifically to certain cells or proteins. The objective is that this treatment will stimulate the patient's immune system to attack those cells. It is possible to create a mAb that is specific to almost any extracellular/cell surface target. Many scientists across the globe are developing such antibodies for diseases like rheumatoid arthritis, Alzheimer's disease, multiple sclerosis, Ebola and different types of cancers.

MARKET DYNAMICS
The monoclonal antibody therapeutics market is anticipated to grow in the forecast period owing to driving factors such as growing demand for monoclonal antibody therapeutics, Increasing drug approvals and launch of novel monoclonal antibodies for treatment of various diseases such as cancer, robust research and development of monoclonal antibodies for various diseases. The market is likely to showcase opportunities for the untapped markets and growing investments into research and development of new antibodies is expected to drive market growth.

MARKET SCOPE
The "Global Monoclonal Antibody Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of monoclonal antibody therapeutics market with detailed market segmentation by type, application, end user and geography. The global monoclonal antibody therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading monoclonal antibody therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global monoclonal antibody therapeutics market is segmented on the basis of type, application and end user. Based on type, the market is segmented as human, humanized, chimeric and others. The monoclonal antibody therapeutics market, based on application is segmented into cancer, autoimmune diseases, infection, hematological diseases and others. On the basis of end user, the global monoclonal antibody therapeutics market is segmented in to hospitals, private clinics and research institutes.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global monoclonal antibody therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The monoclonal antibody therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting monoclonal antibody therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the monoclonal antibody therapeutics market in these regions.


MARKET PLAYERS

The reports cover key developments in the monoclonal antibody therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from monoclonal antibody therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for monoclonal antibody therapeutics market in the global market. Below mentioned is the list of few companies engaged in the monoclonal antibody therapeutics market.

The report also includes the profiles of key monoclonal antibody therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Pfizer Inc.
• Bayer AG
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche Ltd
• Novartis AG
• AbbVie Inc.
• Eli Lilly and Company
• Bristol-Myers Squibb Company

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


TABLE OF CONTENTS

1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Monoclonal Antibody Therapeutics Market- By Type
1.3.2 Monoclonal Antibody Therapeutics Market- By Application
1.3.3 Monoclonal Antibody Therapeutics Market- By End User
1.3.4 Monoclonal Antibody Therapeutics Market- By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY


4. MONOCLONAL ANTIBODY THERAPEUTICS MARKET LANDSCAPE
4.1 MARKET OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis

5. MONOCLONAL ANTIBODY THERAPEUTICS MARKET- KEY INDUSTRY DYNAMICS
5.1 KEY MARKET DRIVERS
5.2 KEY MARKET RESTRAINTS
5.3 KEY MARKET OPPORTUNITIES
5.4 FUTURE TRENDS
5.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. MONOCLONAL ANTIBODY THERAPEUTICS MARKET- GLOBAL ANALYSIS
6.1 MONOCLONAL ANTIBODY THERAPEUTICS MARKET - GLOBAL MARKET OVERVIEW
6.2 MONOCLONAL ANTIBODY THERAPEUTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3 MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. MONOCLONAL ANTIBODY THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - TYPE

7.1 OVERVIEW
7.2 TYPE MARKET FORECASTS AND ANALYSIS
7.3 HUMAN MARKET
7.3.1 Overview
7.3.2 Human Market Revenue Forecasts and Analysis (US$ Mn)
7.4 HUMANIZED MARKET
7.4.1 Overview
7.4.2 Humanized Market Revenue Forecasts and Analysis (US$ Mn)
7.5 CHIMERIC MARKET
7.5.1 Overview
7.5.2 Chimeric Market Revenue Forecasts and Analysis (US$ Mn)
7.6 OTHERS MARKET
7.6.1 Overview
7.6.2 Others Market Revenue Forecasts and Analysis (US$ Mn)

8. MONOCLONAL ANTIBODY THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1 OVERVIEW
8.2 APPLICATION MARKET FORECASTS AND ANALYSIS
8.3 CANCER MARKET
8.3.1 Overview
8.3.2 Cancer Market Forecast and Analysis (US$ Mn)
8.4 AUTOIMMUNE DISEASES MARKET
8.4.1 Overview
8.4.2 Autoimmune Diseases Market Forecast and Analysis (US$ Mn)
8.5 INFECTION MARKET
8.5.1 Overview
8.5.2 Infection Market Forecast and Analysis (US$ Mn)
8.6 HEMATOLOGICAL DISEASES MARKET
8.6.1 Overview
8.6.2 Hematological Diseases Market Forecast and Analysis (US$ Mn)
8.7 OTHERS MARKET
8.7.1 Overview
8.7.2 Others Market Forecast and Analysis (US$ Mn)

9. MONOCLONAL ANTIBODY THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - END USER

9.1 OVERVIEW
9.2 END USER MARKET FORECASTS AND ANALYSIS
9.3 HOSPITALS MARKET
9.3.1 Overview
9.3.2 Hospitals Market Forecast and Analysis (US$ Mn)
9.4 PRIVATE CLINICS MARKET
9.4.1 Overview
9.4.2 Private Clinics Market Forecast and Analysis (US$ Mn)
9.5 RESEARCH INSTITUTE MARKET
9.5.1 Overview
9.5.2 Research Institute Market Forecast and Analysis (US$ Mn)

10. MONOCLONAL ANTIBODY THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1 NORTH AMERICA MONOCLONAL ANTIBODY THERAPEUTICS MARKET
10.1.1 North America Monoclonal Antibody Therapeutics Market Forecasts and Analysis (US$ Mn)
10.1.2 North America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.1.3 North America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.4 North America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.5 North America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Country
10.1.6 US Market Overview
10.1.6.1 US Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.2 US Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.6.3 US Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.7 Canada MARKET OVERVIEW
10.1.7.1 Canada Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.2 Canada Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7.3 Canada Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.8 Mexico Market Overview
10.1.8.1 Mexico Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.2 Mexico Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8.3 Mexico Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2 EUROPE MONOCLONAL ANTIBODY THERAPEUTICS MARKET
10.2.1 Europe Monoclonal Antibody Therapeutics Market Forecasts and Analysis (US$ Mn)
10.2.2 Europe Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.2.3 Europe Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.4 Europe Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.5 Europe Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Country
10.2.6 UK Market Overview
10.2.6.1 UK Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.2 UK Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.6.3 UK Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.7 Germany Market Overview
10.2.7.1 Germany Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.2 Germany Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7.3 Germany Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.8 France Market Overview
10.2.8.1 France Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.2 France Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8.3 France Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.9 Italy Market Overview
10.2.9.1 Italy Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.2.9.2 Italy Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9.3 Italy Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.10 Spain Market Overview
10.2.10.1 Spain Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.2.10.2 Spain Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10.3 Spain Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3 ASIA PACIFIC MONOCLONAL ANTIBODY THERAPEUTICS MARKET
10.3.1 Asia Pacific Monoclonal Antibody Therapeutics Market Forecasts and Analysis (US$ Mn)
10.3.2 Asia Pacific Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.3.3 Asia Pacific Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.4 Asia Pacific Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.5 Asia Pacific Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Country
10.3.6 Japan Market Overview
10.3.6.1 Japan Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.2 Japan Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.6.3 Japan Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.7 India Market Overview
10.3.7.1 India Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.2 India Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7.3 India Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.8 China Market Overview
10.3.8.1 China Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.2 China Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8.3 China Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.9 South Korea Market Overview
10.3.9.1 South Korea Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.3.9.2 South Korea Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9.3 South Korea Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.10 Australia Market Overview
10.3.10.1 Australia Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.3.10.2 Australia Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10.3 Australia Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4 MIDDLE EAST & AFRICA (MEA) MONOCLONAL ANTIBODY THERAPEUTICS MARKET
10.4.1 Middle East & Africa (MEA) Monoclonal Antibody Therapeutics Market Forecasts and Analysis (US$ Mn)
10.4.2 Middle East & Africa (MEA) Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.4.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.5 Middle East & Africa (MEA) Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Country
10.4.6 South Africa Market Overview
10.4.6.1 South Africa Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.2 South Africa Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.6.3 South Africa Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.7 Saudi Arabia Market Overview
10.4.7.1 Saudi Arabia Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.2 Saudi Arabia Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7.3 Saudi Arabia Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.8 UAE Market Overview
10.4.8.1 UAE Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.2 UAE Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8.3 UAE Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.5 SOUTH AND CENTRAL AMERICA MONOCLONAL ANTIBODY THERAPEUTICS MARKET
10.5.1 South and Central America Monoclonal Antibody Therapeutics Market Forecasts and Analysis (US$ Mn)
10.5.2 South and Central America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.5.3 South and Central America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.4 South and Central America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.5 South and Central America Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Country
10.5.6 Brazil Market Overview
10.5.6.1 Brazil Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.2 Brazil Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.6.3 Brazil Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.7 Argentina Market Overview
10.5.7.1 Argentina Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Type (US$ Mn)
10.5.7.2 Argentina Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.7.3 Argentina Monoclonal Antibody Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)

11. INDUSTRY LANDSCAPE
11.1 ORGANIC GROWTH STRATEGIES
11.1.1 New Product Launches
11.1.2 Marketing & Promotional Activities
11.2 INORGANIC GROWTH STRATEGIES
11.2.1 Partnerships, Collaborations, and Joint Ventures
11.2.2 Mergers & Acquisitions

12. MONOCLONAL ANTIBODY THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1 PFIZER INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BAYER AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 SANOFI
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 MERCK & CO., INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GLAXOSMITHKLINE PLC.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. HOFFMANN-LA ROCHE LTD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 NOVARTIS AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ABBVIE INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 BRISTOL-MYERS SQUIBB COMPANY
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ELI LILLY AND COMPANY
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. APPENDIX
13.1 ABOUT THE INSIGHT PARTNERS
13.2 GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Bayer AG
3. Sanofi
4. Merck & Co., Inc.
5. GlaxoSmithKline plc.
6. F. Hoffmann-La Roche Ltd
7. Novartis AG
8. AbbVie Inc.
9. Eli Lilly and Company
10. Bristol-Myers Squibb Company
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book